Cite
HARVARD Citation
Klil‐Drori, A. et al. (n.d.). Early switch to second‐line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response. American journal of hematology. 92 (10), pp. E602-E604. [Online].